Prognostic impact of fibrinogen in patients with resistant hypertension
Yazarlar (6)
Doç. Dr. Uğur Köktürk Zonguldak Bülent Ecevit Üniversitesi, Türkiye
Hamdi Püşüroğlu
Türkiye
Türkiye
İlyas Çetin Türkiye
Prof. Dr. Mustafa Umut Somuncu Türkiye
Prof. Dr. Ahmet AVCI Türkiye
Öğr. Gör. Mehmet Ertürk Türkiye
| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Journal of Human Hypertension (Q2) | ||
| Dergi ISSN | 0950-9240 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 10-2024 |
| Cilt / Sayı / Sayfa | 38 / 12 / 860–866 | DOI | 10.1038/s41371-024-00964-9 |
| Makale Linki | https://doi.org/10.1038/s41371-024-00964-9 | ||
| Özet |
| In this study, we investigated the long-term prognostic effects of fibrinogen levels in patients with resistant hypertension. A total of 266 patients with resistant hypertension who had serum fibrinogen measurements and 5 years of follow-up information were retrospectively included in the study. The patients were stratified according to their fibrinogen levels, which were then divided into tertiles. Clinical outcomes for major adverse cardiovascular events (MACE) were assessed at 5 years. MACE was defined as all-cause mortality, cardiovascular mortality, non-fatal myocardial infarction (MI), non-fatal stroke, a new diagnosis of heart failure, or hospitalization for heart failure and peripheral arterial disease. The incidence of MACE at 5 years in patients with resistant hypertension was higher in the highest tertile of fibrinogen. Multivariate analysis identified fibrinogen as an independent predictor of MACE in patients with … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 1 |